Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2017-04-28 | He received a Bachelor's degree from Miami University and a Master's degree from the University of Chicago. |
| 2018-04-27 | Mr. Essner's significant executive leadership experience in the pharmaceutical industry, including building and leading pharmaceutical businesses, launching products and managing corporate risks. |
| 2019-04-29 | He received a Bachelor's degree from Miami University and a Master's degree from the University of Chicago. |
| 2020-04-24 | He received a Bachelor’s degree from Miami University and a Master’s degree from the University of Chicago. |
| 2021-04-27 | Robert Essner has served as a member of the Board since June 2012. Mr. Essner retired as Chairman and Chief Executive Officer of Wyeth Pharmaceuticals, Inc., now part of Pfizer Inc., in 2008. During his 32year career in the pharmaceutical industry, he held several prominent leadership positions, including Chairman of the Pharmaceutical Research and Manufacturers Association. Prior to Wyeth, Mr. Essner spent more than a decade in various management positions at Sandoz Pharmaceuticals Corporation and as President of Sandoz Consumer Healthcare Group. Mr. Essner was formerly a Director at MassMutual Financial Group. He received a Bachelor’s degree from Miami University and a Master’s degree from the University of Chicago. |
| 2022-04-26 | He received a Bachelor’s degree from Miami University and a Master’s degree from the University of Chicago. |
Data sourced from SEC filings. Last updated: 2026-02-03